Cubit Lifesciences Llp Profile
Key Indicators
- Obligation of Contribution ₹ 3.00 Cr
as on 21-01-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 49.96 Cr
as on 21-01-2024
- Revenue 32.81%
(FY 2021)
- Profit -66.34%
(FY 2021)
- Ebitda 10.98%
(FY 2021)
- Total Assets 17.94%
(FY 2021)
About Cubit Lifesciences Llp
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 3.00 Cr as per MCA.
- CIN/LLPIN/FCRN
AAM-8820
- Incorporation Date
28 Jun 2018
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Ahmedabad
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cubit Lifesciences Llp?
Designated Partners(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shalini Agrawal | Designated Partner | 05-Oct-2018 | Current |
Prabhat Agrawal | Designated Partner | 28-Jun-2018 | Current |
Ravi Agrawal | Designated Partner | 24-Aug-2023 | Current |
Ashok Agrawal | Designated Partner | 28-Jun-2018 | Current |
Priyanka Agrawal | Designated Partner | 05-Oct-2018 | Current |
Financial Performance and Corporate Structure Insights of Cubit Lifesciences Llp.
Cubit Lifesciences Llp, for the financial year ended 2021, experienced significant growth in revenue, with a 32.81% increase. The company also saw a substantial fall in profitability, with a 66.34% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth | |||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Cubit Lifesciences Llp?
Unlock access to Cubit Lifesciences Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Cubit Formulations Private LimitedActive 4 years 9 months
Prabhat Agrawal, Ashok Agrawal and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 04 May 2019 | ₹24.98 Cr | Open |
State Bank Of India Creation Date: 03 May 2019 | ₹24.98 Cr | Open |
How Many Employees Work at Cubit Lifesciences Llp?
Cubit Lifesciences Llp has a workforce of 65 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cubit Lifesciences Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cubit Lifesciences Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.